The latest Digital Health News industry roundup includes TidalSense raising money to build out its diagnostics system, Paige introducing advanced integration capabilities to its platform and Excelerate taking NHS England and an ambulance trust to court.
Cambridge-based healthtech (formerly Cambridge Respiratory Innovations) TidalSense has raised Ā£7.5 million, led by BGF and Downing. The company is using AI to produce diagnostics and monitoring solutions for respiratory diseases.
It has created a handheld medical device called N-Tidal that uses patented sensor technology and AI to diagnose COPD within a few minutes, with asthma soon to follow.
The capital will be used to build out the company’s diagnostics business further, targeting the primary care and diagnosis provider market in the UK.
In England alone, respiratory diseases affect one in five people and are the third biggest cause of death. According to NHS England, the annual economic burden of COPD and asthma are estimated at Ā£4.9 billion, with the majority of costs associated with hospitalisations.
Early detection and diagnosis have the potential to slow the trajectory of the disease and reduce these costs. Globally, the COPD and asthma diagnostics and monitoring market is estimated to be $8.2 billion p/a.
Paige introduces advanced integration capabilities to its platform
Paige, a global leader in end-to-end digital pathology solutions and clinical AI applications that assist in diagnosing cancer, today introduced new advanced integration capabilities to the Paige Platform, a holistic web-based solution that enables complete digital pathology workflows and supports the evolving needs of todayās modern lab.
With Paigeās flexible platform at the nexus of the digital pathology ecosystem, labs and pathologists can connect their existing and future digital pathology applications into a single environment managed by Paige. The Platformās flexibility is powered by a set of APIs that allow for unlimited vendor-neutral integrationsā and enable custom workflows to be built on top of Paigeās already robust native capabilities.
In addition to integrating within the workflow, the solution enables seamless access to both Paigeās AI solutions and third-party AI applications. This helps to support labs in taking an iterative approach to digital pathology adoption, reducing upfront investment, avoiding vendor lock-in and making the digital transition a frictionless experience for the entire pathology department.
Excelerate takes legal action against NHS England and ambulance trust
Technology company
Excelerate is taking NHS England and an ambulance trust to court over alleged bias in a tender.
In claim papers filed at the Technology and Construction Court (part of the High Court), Excelerate Technology said it was sent a secret WhatsApp recording of a crucial meeting which, it alleges, shows West Midlands Ambulance Service University Foundation Trust and NHS England were āconsciously biased against itā and āwere intent on reducing and eventually eliminat[ing]ā its future involvement as a supplier.
The company, which provides communications technology for emergency response vehicles, is claiming the procurement for the national ambulance resilience team (known as NARU) ā which is hosted by WMAS and funded by NHSE ā showed misfeasance in public office by WMAS and NHSE. Excelerate also alleges WMAS breached contract and procurement law.
The court papers show the company is alleging āunlawfulā decisions made by NARU, under the management of procurement manager Laura Johnson, ācan only be explained by deliberate decisions to act unlawfully or by conscious recklessness to whether WMASās conduct was unlawfulā, while Mike Shanahan, NHSEās deputy director of resilience, was biased against the company and refused to take steps to prevent or rectify WMASās conduct.
The recording allegedly contains a remark made during a meeting about being biased against Excelerate. In NHSEās court submission, it suggests Mr Shanahan did make the remark but āin jestā, and it was followed by laughter from others in the room.
Excelerate alleges Ms Johnson then said this remark should not be minuted. WMAS argues that, if this happened, it would have been appropriate to say something said as a joke should not be minuted.
Log my Care launches new person-centred care feature
Log my Care, the platform for outstanding care management, has launched Outcomes and Goals, a new feature designed to transform person-centred care. This enables care managers to set goals, create action plans, add documents and track and evidence goalsā progress from one central place.
The feature makes it easier for care providers to coordinate their team’s efforts towards achieving specific goals for the people they support and empowers them to take positive risks and develop independence.
By setting and working towards specific goals that matter most to them, those accessing care can develop a sense of purpose and fulfilment, enhancing their overall well-being.
Log my Care’s mission is to make person-centred technology accessible to everybody in social care, transforming care for society’s most vulnerable people.
This new feature means care providers can empower the people they support to achieve what matters most to them, promoting their independence and enhancing their quality of life.
Intelerad integrates Augnito voice recognition
Augnito Voice ServicesĀ will integrate with Inteleradās InSight PACS reporting, equipping clients with accessible, advanced speech recognition technology that simplifies patient care.
This new integration partnership will provide Intelerad clients with increased voice recognition options, giving them access to a pioneering, cloud–based product that helps ensure clients are not limited to one voice recognition platform and the risks associated with that dependence.
Intelerad Cloud is a menu of expertly cloud-engineered solutions designed to optimise the benefits of Cloud technology and scalability potential without sacrificing the performance of onsite architecture.
Proudly vendor-neutral, Intelerad, is integrating its products with multiple technologies which fit with its cloud–based strategy, Augnito being the most recent.
These can assist with the Cloud First strategy by utilising the Cloud for disaster recovery, image exchange and long-term archiving, and this latest addition is another way Intelerad is providing the latest cloud innovations and future resilience required by its clients.Ā Ā
Augnito can be used with a speech microphone or even through an app on a smartphone, making it faster and easier for radiologists and clinicians to diagnose critical conditions where every second counts, leading to better outcomes for patients.Ā
